BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24063967)

  • 1. Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.
    Hwang N; Nandra R; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
    Eur J Surg Oncol; 2014 Apr; 40(4):429-34. PubMed ID: 24063967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humeral metastasis of renal cancer: Surgical options and review of literature.
    Casadei R; Drago G; Di Pressa F; Donati D
    Orthop Traumatol Surg Res; 2018 Jun; 104(4):533-538. PubMed ID: 29654934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthopaedic management of bony metastases of renal cancer.
    Pongracz N; Zimmerman R; Kotz R
    Semin Surg Oncol; 1988; 4(2):139-42. PubMed ID: 3393777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment for pathologic fracture.
    Wedin R
    Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular endoprosthetic replacement for tumours of the proximal femur.
    Chandrasekar CR; Grimer RJ; Carter SR; Tillman RM; Abudu A; Buckley L
    J Bone Joint Surg Br; 2009 Jan; 91(1):108-12. PubMed ID: 19092014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Is the Prosthetic Survival After Resection and Intercalary Endoprosthetic Reconstruction for Diaphyseal Bone Metastases of the Humerus and Femur?
    Johnson JD; Satcher RL; Feng L; Lewis VO; Moon BS; Bird JE; Lin PP
    Clin Orthop Relat Res; 2023 Nov; 481(11):2200-2210. PubMed ID: 37185204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical resection of brain metastases from renal cell carcinoma in 50 patients.
    Wroński M; Arbit E; Russo P; Galicich JH
    Urology; 1996 Feb; 47(2):187-93. PubMed ID: 8607231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient survival after surgery for osseous metastases from renal cell carcinoma.
    Lin PP; Mirza AN; Lewis VO; Cannon CP; Tu SM; Tannir NM; Yasko AW
    J Bone Joint Surg Am; 2007 Aug; 89(8):1794-801. PubMed ID: 17671020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
    Assouad J; Banu E; Brian E; Pham DN; Dujon A; Foucault C; Riquet M
    Eur J Cardiothorac Surg; 2008 May; 33(5):794-8. PubMed ID: 18304831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention.
    Kollender Y; Bickels J; Price WM; Kellar KL; Chen J; Merimsky O; Meller I; Malawer MM
    J Urol; 2000 Nov; 164(5):1505-8. PubMed ID: 11025692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
    Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
    Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of osseous metastases in patients with renal cell carcinoma.
    Dürr HR; Maier M; Pfahler M; Baur A; Refior HJ
    Clin Orthop Relat Res; 1999 Oct; (367):283-90. PubMed ID: 10546626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of surgery in bone metastases of renal cell carcinoma: 13 case reports].
    Le Mouel S; Gaston A; Paule B
    Prog Urol; 2008 Dec; 18(13):1045-9. PubMed ID: 19041809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impending and actual pathological fractures in patients with bone metastases of the long bones. A retrospective study of 233 surgically treated fractures.
    Dijstra S; Wiggers T; van Geel BN; Boxma H
    Eur J Surg; 1994 Oct; 160(10):535-42. PubMed ID: 7849154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and survival of osseous renal cell carcinoma metastases.
    Evenski A; Ramasunder S; Fox W; Mounasamy V; Temple HT
    J Surg Oncol; 2012 Dec; 106(7):850-5. PubMed ID: 22623216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?
    Gutowski CJ; Zmistowski B; Fabbri N; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2019 Apr; 477(4):707-714. PubMed ID: 30811363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma.
    Althausen P; Althausen A; Jennings LC; Mankin HJ
    Cancer; 1997 Sep; 80(6):1103-9. PubMed ID: 9305711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.